Related Experiment Video
Updated: Jul 24, 2025
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Updates in the Use of Immunohistochemical Stains in Breast and Gynecologic Pathology
Taylor M Jenkins1, Chelsea R Mehr2
1From the Department of Pathology, University of Virginia Health System, Charlottesville (Jenkins).
Context.—:
The use of immunohistochemical stains in breast and gynecologic pathology has become increasingly complex, with various diagnostic, prognostic, and predictive applications.
Objective.—:
To provide an update and review of immunohistochemical stains used in the practice of breast and gynecologic pathology. Established and new entities are reviewed, with descriptions of histomorphology and immunohistochemical staining patterns and discussion of interpretive pitfalls.
Data Sources.—:
Data were obtained from review of the English-language literature and firsthand experience of the authors in breast and gynecologic pathology.
Conclusions.—:
Many entities in breast and gynecologic pathology benefit from evaluation with various immunohistochemical stains. These studies not only aid in the diagnosis and staging of tumors but also can provide prognostic and predictive information. Updated guidelines for recommended ancillary studies such as mismatch repair, p53, and human epidermal growth factor receptor 2 (HER2) studies in endometrium, as well as estrogen and progesterone receptors and HER2 in breast, are discussed. Finally, the use and interpretation of established and novel immunohistochemical stains are discussed in various breast and gynecologic malignancies.
